Navigation Links
Childhood Brain Tumors May Respond to Measles Virus

Treatment looks promising in laboratory and animal tests, researchers say

WEDNESDAY, June 2 (HealthDay News) -- A modified form of the measles virus could become a treatment for a kind of brain tumor in children, researchers report.

The tumor, known as medulloblastoma, occurs in about 20 percent of childhood brain cancer cases. Treatment, which can include surgery, radiation and chemotherapy, has increased the survival rate at five years to 70 percent, but the tumors remain deadly in many cases.

"There is still an urgent need to investigate alternative therapeutic approaches that are more effective and have less toxic side effects," said study lead author Dr. Corey Raffel, chief of neurosurgery at Nationwide Children's Hospital in Columbus, Ohio.

Researchers have previously used strains of measles virus to kill different types of tumor cells.

In this study, researchers found that a modified form of the measles virus killed brain tumor cells in the laboratory. The approach seemed to also work in mice with tumors similar to medulloblastomas in humans.

More research is needed before the treatment will be ready for testing in people.

The findings were published online May 21 in the journal Neuro-Oncology.

More information

For more about childhood brain tumors, see the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCE: Nationwide Children's Hospital, news release, May 26, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Childhood Obesity Institute Symposium at Children's National Medical Center Zeroes in on the Importance of Multi-Disciplinary Approach to Curb Childhood Obesity
2. Childhood Cancer Survivors Face Health Problems Throughout Life
3. First-ever World Health Assembly resolution to fight childhood pneumonia
4. Heart Disease Among Childhood Cancer Survivors Tied to Gene Mutations
5. High-fat ketogenic diet effectively treats persistent childhood seizures
6. Rate of Childhood Peanut Allergies More Than Triples
7. Childhood psychological problems create long-term economic losses, study finds
8. Rate of childhood peanut allergies more than tripled from 1997 to 2008
9. No Link Between Childhood Infections, Autism
10. Survivors of childhood cancers 4 times more likely to develop post-traumatic stress disorder
11. The childhood obesity epidemic: How do we stop it?
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... for the care management and population health arenas, is pleased to announce that ... cost containment services, has successfully implemented the ACUITY Complete Care™ Management to back ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Arash Moradzadeh ... Man for 2015. , Angeleno Magazine is a division of Modern Luxury, ... 1994, Modern Luxury includes more than 50 magazine titles across 15 major markets. ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announced today that it has officially launched a sleek, mobile-ready and user-centric redesigned ... his company’s new website clearly outlines the benefits that its SEO services provide ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 Breg, Inc ., a premier ... that it has been awarded three contracts by Novation, ... Novation will have access to improved pricing for Breg,s ... soft goods dedicated to advancing orthopedic care.  ... U.S. population, rising prevalence of chronic conditions and the ...
(Date:12/1/2015)... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... has always been a country of choice for global multi-center ... Europe in 2015 were tested in phase II-III clinical ... has always been a country of choice for global multi-center phase III ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: